Cargando…

Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients

BACKGROUND: Chemoresistance is problematic and its mechanisms are unclear in breast cancer. More predictive markers are urgently required. METHODS: GSE32646, GSE34138, and GSE20271 were downloaded from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs) betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Na, Xie, Peilin, Chen, Heyan, Li, Yijun, Zhao, Yuting, He, Jianjun, Zhang, Huimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906202/ https://www.ncbi.nlm.nih.gov/pubmed/36760254 http://dx.doi.org/10.21037/atm-22-6319

Ejemplares similares

Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation
por: O’Shea, Nuala R., et al.
Publicado: (2016)

Metalloendopeptidase ADAM-like Decysin 1 (ADAMDEC1) in Colonic Subepithelial PDGFRα(+) Cells Is a New Marker for Inflammatory Bowel Disease
por: Ha, Se Eun, et al.
Publicado: (2022)

ADAM-like Decysin-1 (ADAMDEC1) is a positive regulator of Epithelial Defense Against Cancer (EDAC) that promotes apical extrusion of RasV12-transformed cells
por: Yako, Yuta, et al.
Publicado: (2018)

ADAMDEC1 accelerates GBM progression via activation of the MMP2-related pathway
por: Qi, Huimin, et al.
Publicado: (2022)

Biological potentials for a family of disintegrin and metalloproteinase (ADAMDEC)-1 in mouse normal pregnancy
por: KUNIYOSHI, Nobue, et al.
Publicado: (2021)

Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of COBLL1 and the ADAM28-ADAMDEC1 Locus via Interaction with the Histone Lysine Demethylase KDM2B
por: Gillman, Adam C. T., et al.
Publicado: (2018)

Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains
por: Plaza-Díaz, Julio, et al.
Publicado: (2017)

Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non‐small cell lung cancer (NSCLC) via the PI3K/AKT pathway
por: Zhu, Weiliang, et al.
Publicado: (2022)

The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)
por: Li, Yijun, et al.
Publicado: (2023)

A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm
por: Li, Yijun, et al.
Publicado: (2022)

Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based study
por: Pu, Shengyu, et al.
Publicado: (2023)

Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells
por: Liu, Haiyan, et al.
Publicado: (2009)

Bioinformatics analysis for the role of CALR in human cancers
por: Li, Yijun, et al.
Publicado: (2021)

LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11
por: Sagane, Koji, et al.
Publicado: (2008)

A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database
por: Li, Yijun, et al.
Publicado: (2020)

Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
por: Zheng, Hui, et al.
Publicado: (2019)

The nodal positivity rate in breast pCR patients with initially, clinically node-negative breast cancer after neoadjuvant systemic therapy: A systematic review and meta-analysis
por: Ma, Le, et al.
Publicado: (2023)

ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma
por: Belisario, Dimas Carolina, et al.
Publicado: (2020)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer
por: Zhang, Xin, et al.
Publicado: (2019)

Evolution of Vertebrate Adam Genes; Duplication of Testicular Adams from Ancient Adam9/9-like Loci
por: Bahudhanapati, Harinath, et al.
Publicado: (2015)

Clinicopathological Features and Prognosis Analysis of Primary Bile Duct and Ampullary Neuroendocrine Neoplasms: A Population-Based Study from 1975 to 2016
por: Li, Yijun, et al.
Publicado: (2022)

ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance
por: Orme, Jacob J., et al.
Publicado: (2020)

ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc
por: Cheng, Yuanyuan, et al.
Publicado: (2021)

Hypoxia-mediated radiation and chemo-sensitizing drugs.
por: Adams, G. E.
Publicado: (1984)

ADAM12 is an independent predictor of poor prognosis in liver cancer
por: Du, Shuangqiu, et al.
Publicado: (2022)

BAG1 down‐regulation increases chemo‐sensitivity of acute lymphoblastic leukaemia cells
por: Mariotto, Elena, et al.
Publicado: (2021)

FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers
por: Mesquita, Katia A., et al.
Publicado: (2021)

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients
por: Bai, Tuya, et al.
Publicado: (2017)

Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17
por: Alabi, Rolake O., et al.
Publicado: (2021)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

The collectrin‐like part of the SARS‐CoV‐1 and ‐2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17
por: Niehues, Rabea Victoria, et al.
Publicado: (2022)

(1-Adamantyl)diphenylmethanol
por: Vícha, Robert, et al.
Publicado: (2010)

Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
por: Sammel, Martin, et al.
Publicado: (2019)

Adam
Publicado: (1880)

Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma
por: You, Bo, et al.
Publicado: (2015)

ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma
por: Xu, Jun Hui, et al.
Publicado: (2021)

Sensitization of Chemo-Resistant Human Chronic Myeloid Leukemia Stem-Like Cells to Hsp90 Inhibitor by SIRT1 Inhibition
por: Kim, Hak-Bong, et al.
Publicado: (2015)

Evaluation of the efficacy of chemotherapy for tubular carcinoma of the breast: A Surveillance, Epidemiology, and End Results cohort study
por: Zhao, Yuting, et al.
Publicado: (2023)

Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis
por: Liu, Xing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pdhafvjvqvt44lqpul3tk1k15c